ClinicalTrials.gov
ClinicalTrials.gov Menu

Cetuximab, Capecitabine and Oxaliplatin in Patients With Epidermal Growth Factor Receptor (EGFr) Expressing Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00444678
Recruitment Status : Completed
First Posted : March 8, 2007
Last Update Posted : February 27, 2018
Sponsor:
Collaborators:
ImClone LLC
Bristol-Myers Squibb
Information provided by (Responsible Party):
New York University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 1, 2012
  Actual Study Completion Date : June 1, 2015